We are live on ! Find out more
SR

Summer Road Portfolio holdings

AUM $161M
1-Year Est. Return 27.24%
This Fund
S&P 500
This Quarter Est. Return
+28.13%
1 Year Est. Return
+27.24%
3 Year Est. Return
+129.62%
5 Year Est. Return
-16.44%
10 Year Est. Return
+274.48%
AUM
$29.1M
AUM Growth
+$18.6M
Cap. Flow
+$17M
Cap. Flow %
58.65%
Top 10 Hldgs %
100%
Holding
2
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
OCUL icon
Ocular Therapeutix
OCUL
+$17M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 67.84%
2 Consumer Discretionary 32.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OCUL icon
1
Ocular Therapeutix
OCUL
$2.38B
$19.7M 67.84%
+3,027,488
New +$17M
SKIS
2
DELISTED
Peak Resorts, Inc.
SKIS
$9.34M 32.16%
1,926,500
– –

Similar funds

SFCM
Savoir Faire Capital Management Norwalk, Connecticut $161M AUM 3.8% 1-Year Est. Return
LWM
Lighthouse Wealth Management Ashland, Ohio $161M AUM 19.46% 1-Year Est. Return
MWM
Mascagni Wealth Management Clinton, Mississippi $161M AUM 26.58% 1-Year Est. Return
MCM
MidAtlantic Capital Management Richmond, Virginia $161M AUM 18.73% 1-Year Est. Return
BFS
Burr Financial Services Pleasant Hill, California $161M AUM 80.86% 1-Year Est. Return
MMCM
Murphy & Mullick Capital Management Smithtown, New York $161M AUM 39.43% 1-Year Est. Return
MWA
Merkkuri Wealth Advisors Hicksville, New York $161M AUM 19.9% 1-Year Est. Return
BWM
Bosman Wealth Management Redlands, California $161M AUM 115.22% 1-Year Est. Return

Summer Road's Q1 2018 Portfolio in Review

As of Q1 2018, Summer Road held 2 positions worth $29.1M, up 179% from $10.4M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Summer Road deployed $17M of net new capital in Q1 2018, opening 1 new position. Its largest new stake was Ocular Therapeutix: 3,027,488 shares worth $19.7M.

By sector, the portfolio is most concentrated in Healthcare at 68% of assets, followed by Consumer Discretionary.

  • Summer Road's largest Q1 2018 buy was Ocular Therapeutix: 3,027,488 shares worth $19.7M.
  • Summer Road's ten largest holdings make up 100% of its $29.1M portfolio in Q1 2018.
  • Summer Road opened 1 new position and closed 0 in Q1 2018.
  • Summer Road's portfolio value rose 179% quarter-over-quarter to $29.1M.

Based on Summer Road's 13F filing for Q1 2018, filed 8 May 2018.